Royal Bank of Canada
NEOS

Royal Bank of Canada’s Neos Therapeutics, Inc NEOS Stock Holding History

Royal Bank of Canada’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,100
Closed -$3K – 7181
2020
Q2 		$3K Hold
4,100
– – ﹤0.01% 6240
2020
Q1 		$3K Sell
4,100
-4,000
-49% -$5.5K ﹤0.01% 6247
2019
Q4 		$12K Hold
8,100
– – ﹤0.01% 6091
2019
Q3 		$12K Sell
8,100
-4,500
-36% -$7.28K ﹤0.01% 5728
2019
Q2 		$16K Hold
12,600
– – ﹤0.01% 5830
2019
Q1 		$33K Buy
12,600
+12,598
+629,900% +$29.5K ﹤0.01% 5399
2018
Q4 		$0 Sell
2
-1,139
-100% -$3.2K ﹤0.01% 7355
2018
Q3 		$5K Sell
1,141
-1,494
-57% -$8.47K ﹤0.01% 6305
2018
Q2 		$17K Buy
2,635
+2,127
+419% +$15.9K ﹤0.01% 5621
2018
Q1 		$4K Sell
508
-355
-41% -$3.39K ﹤0.01% 6014
2017
Q4 		$9K Sell
863
-2,371
-73% -$22.8K ﹤0.01% 5921
2017
Q3 		$30K Buy
3,234
+2,316
+252% +$17.6K ﹤0.01% 5736
2017
Q2 		$6K Sell
918
-490
-35% -$3.7K ﹤0.01% 6002
2017
Q1 		$10K Sell
1,408
-352
-20% -$2.18K ﹤0.01% 5991
2016
Q4 		$10K Buy
1,760
+1,010
+135% +$6.83K ﹤0.01% 6101
2016
Q3 		$5K Hold
750
– – ﹤0.01% 5982
2016
Q2 		$7K Hold
750
– – ﹤0.01% 5871
2016
Q1 		$8K Buy
+750
New +$7.91K ﹤0.01% 5816
2015
Q4 		– Sell
-200
Closed -$4K – 6930
2015
Q3 		$4K Buy
+200
New +$4.41K ﹤0.01% 6249

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's NEOS Position: Q3 2020 in Review

Royal Bank of Canada sold out of Neos Therapeutics, Inc (NEOS) in Q3 2020, closing a stake of 4,100 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in NEOS in Q3 2015 and held it in 19 quarters. The position peaked at $33K in Q1 2019. 41 funds tracked by Wall St. Rank hold NEOS as of Q3 2020.

  • Royal Bank of Canada reported no remaining Neos Therapeutics, Inc position as of Q3 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 4,100 Neos Therapeutics, Inc shares in Q3 2020, an estimated $3K.
  • Royal Bank of Canada first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 19 quarters.
  • Royal Bank of Canada's Neos Therapeutics, Inc position peaked at $33K in Q1 2019.
  • 41 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2020.

Based on Royal Bank of Canada's 13F filing for Q3 2020, filed 16 Nov 2020.